Patient data meta‐analysis of Post‐Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated with rAHF ‐PFM-Reference-Cited by-同舟云学术

Patient data meta‐analysis of Post‐Authorization Safety Surveillance (PASS) studies of haemophilia A patients treated with rAHF ‐PFM

Published:2014-07-17 Issue:6 Volume:20 Page:777-783
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Iorio A.¹,Marcucci M.¹²,Cheng J.¹³,Oldenburg J.⁴,Schoenig‐Diesing C.⁵,Matovinovic E.⁵,Romanov V.⁵,Thabane L.¹³

Affiliation:

1. Department of Clinical Epidemiology & Biostatistics McMaster University Hamilton ON Canada

2. Geriatrics Foundation IRCCS Ca' Granda – Ospedale Maggiore Policlinico & Department of Clinical Sciences and Community Health University of Milan Milan Italy

3. Biostatistics Unit St Joseph's Healthcare—Hamilton Hamilton ON Canada

4. Institute of Experimental Haematology and Transfusion Medicine University Clinic Bonn Bonn Germany

5. Global Medical Affairs Baxter Healthcare Corporation Westlake Village California USA

Funder

Baxter International

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12480

Reference33 articles.

2. The epidemiology of inhibitors in haemophilia A: a systematic review

3. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review

4. Inhibitor development in previously treated hemophilia A patients: a systematic review, meta-analysis, and meta-regression

5. A Higher than Expected Incidence of Factor VIII Inhibitors in Multitransfused Haemophilia A Patients Treated with an Intermediate Purity Pasteurized Factor VIII Concentrate

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients;Medicina;2023-12-24

2. Cost-Effectiveness Analysis of Pharmacokinetic-Guided Prophylaxis Versus Standard Prophylaxis in Adults with Severe Hemophilia A in China;Advances in Therapy;2022-06-30

3. Final Results of the Prospective ADVATE® Immune Tolerance Induction Registry (PAIR) Study with Plasma- and Albumin-Free Recombinant Factor VIII;Journal of Blood Medicine;2021-11

4. Postauthorization safety surveillance study of antihaemophilic factor (recombinant) reconstituted in 2 mL sterile water for injection in children with haemophilia A;Haemophilia;2020-04-27

5. Inhibitor development, safety and efficacy of Advate® among previously treated patients with hemophilia A in a postmarketing surveillance in Japan;International Journal of Hematology;2019-01-02